参天製薬株式会社
Summary
参天製薬株式会社 is registered in Japan and entered in the “Companies Registration” under number 1200-01-051819. Its legal form is 株式会社 (株) – joint-stock company (Japan). 参天製薬株式会社 is the ultimate parent of a group of 2 subsidiaries in 3 countries, as reported to GLEIF. GLEIF gives this reason: no known person controls the entity, for example because its shareholders are diverse. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 1 Mar 2019 and the record was last updated on 1 Mar 2026; the next renewal is due by 1 Mar 2027. GLEIF's ISIN mapping lists 2 ISINs for this LEI.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | 株式会社 (株) joint-stock company (Japan) |
|---|---|
| Register | Companies Registration · Register website |
| Registration number | 1200-01-051819 |
| Registration authority | Legal Affairs Bureau |
| Jurisdiction | Japan |
| Registered address | 大深町４番20号, 530-8552 大阪府 大阪市北区, Japan |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 3 Jul 1925 |
| LEI | 529900TPT3I7C17MIM03 |
| LEI status | active |
| LEI first issued | 1 Mar 2019 |
| LEI record last updated | 1 Mar 2026 |
| Next LEI renewal | 1 Mar 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Parent not reported to GLEIF
- Direct parent: no known person controls the entity, for example because its shareholders are diverse.
- Ultimate parent: no known person controls the entity, for example because its shareholders are diverse.
Direct subsidiaries (1)
- Santen Oy Finland · TAMPERE
ISINs mapped to this LEI (2)
JP3336000009 · US80287P1003
2 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.
Other names
- Santen Pharmaceutical Co., Ltd. · name in another language